Dr. Robert David Kemp, MD

Dr. Kemp practices at DaVita Goldsboro South Dialysis in Goldsboro, North Carolina.

Dr. Kemp's NPI, 1932293131, was assigned on October 3, 2006. Dr. Kemp holds North Carolina license 009400540.

Dr. Kemp's primary practice is DaVita Goldsboro South Dialysis, at 1704 Wayne Memorial Drive, Goldsboro, NC 27530 in Wayne County. The practice phone is (919) 739-6505.

Dr. Kemp's primary practice is DaVita Goldsboro South Dialysis in Goldsboro, North Carolina. Dr. Kemp is also affiliated with UNC Health Wayne. The medical group on file is UNC Health Wayne. Dmand AI also links Dr. Kemp to 1 more hospital, 4 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kemp practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kemp's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kemp is licensed in North Carolina.

CMS data shows 806 Medicare services from Dr. Kemp across 8 procedure codes in 2024, for 211 Medicare patients. Medicare paid $104,963 for them.

CMS counts 211 Medicare patients who saw Dr. Kemp in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kemp's median patient age at 71, with 49% women.

In 2024, Dr. Kemp wrote 835 Medicare Part D claims for 165 patients. 97% of them were for generic drugs. CMS names the drug for 643 of them, across 17 drugs with 11 or more claims each, at $13,997 in total drug cost. In 2023, CMS named 888 claims across 18 drugs.

Dr. Kemp accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Kemp, published from 2012 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Australia, Queensland and Substance Abuse, Intravenous. Dr. Kemp has published most often in Drug Alcohol Rev.

CMS Open Payments shows 13 general payments to Dr. Kemp from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Fresenius USA Marketing, Inc. paid the most, $63.